The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Genentech
Stock and Other Ownership Interests - Roche Pharma AG
Travel, Accommodations, Expenses - Genentech
Prospective assessment of quality of life in patients with advanced NSCLC treated in real world community oncology settings: Effects of initial treatment regimen and disease progression.
 
Mark S. Walker
Consulting or Advisory Role - Genentech (Inst); GlaxoSmithKline (Inst); Merck (Inst); Onyx (Inst); Sanofi (Inst)
Research Funding - Genentech (Inst); GlaxoSmithKline (Inst); Onyx (Inst); Sanofi (Inst)
 
Hans-Peter Goertz
Employment - Genentech
Stock and Other Ownership Interests - Roche Pharma AG
Travel, Accommodations, Expenses - Genentech
 
Arliene Ravelo
No Relationships to Disclose
 
Sebastien Hazard
Employment - Genentech
Stock and Other Ownership Interests - Roche Pharma AG
Travel, Accommodations, Expenses - Genentech
 
Paul J. E. Miller
Research Funding - Genentech (Inst); GlaxoSmithKline (Inst); Onyx (Inst); Sanofi (Inst)
 
Lee Steven Schwartzberg
Leadership - Vector Oncology
Consulting or Advisory Role - Amgen; Eisai; Genentech; Teva
Speakers' Bureau - Eisai; Genentech; Novartis
Research Funding - Eisai